User menu

A FRAX® model for the assessment of fracture probability in Belgium.

Bibliographic reference Johansson, H ; Kanis, J A ; McCloskey, E V ; Odén, A ; Devogelaer, Jean-Pierre ; et. al. A FRAX® model for the assessment of fracture probability in Belgium.. In: Osteoporosis International : with other metabolic bone diseases, Vol. 22, no. 2, p. 453-61 (2011)
Permanent URL
  1. Kanis John A., Melton L. Joseph, Christiansen Claus, Johnston Conrad C., Khaltaev Nikolai, The diagnosis of osteoporosis, 10.1002/jbmr.5650090802
  2. Looker A. C., Wahner H. W., Dunn W. L., Calvo M. S., Harris T. B., Heyse S. P., Johnston Jr C. C., Lindsay R., Updated Data on Proximal Femur Bone Mineral Levels of US Adults, 10.1007/s001980050093
  3. Kanis John A., McCloskey Eugene V., Johansson Helena, Oden Anders, Melton L. Joseph, Khaltaev Nikolai, A reference standard for the description of osteoporosis, 10.1016/j.bone.2007.11.001
  4. Kanis J. A., Delmas P., Burckhardt P., Cooper C., Torgerson D., Guidelines for diagnosis and management of osteoporosis, 10.1007/bf01623782
  5. Kanis on behalf of the World Health Organization Scientific Group. JA (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK.
  6. European Community. Report on osteoporosis in the European Community. 1998. EC, Strasbourg
  7. Royal College of Physicians (1999) Osteoporosis: clinical guidelines for the prevention and treatment. Royal College of Physicians, London
  8. Kanis J.A, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A, Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis, 10.1016/s8756-3282(00)00381-1
  9. Schuit S.C.E, van der Klift M, Weel A.E.A.M, de Laet C.E.D.H, Burger H, Seeman E, Hofman A, Uitterlinden A.G, van Leeuwen J.P.T.M, Pols H.A.P, Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study, 10.1016/j.bone.2003.10.001
  10. Kanis J. A., Johnell O., Oden A., Jonsson B., Dawson A., Dere W., Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden : , 10.1007/pl00004173
  11. Kanis J. A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., Burckhardt P., Cooper C., Christiansen C., Cummings S., Eisman J. A., Fujiwara S., Glüer C., Goltzman D., Hans D., Krieg M.-A., La Croix A., McCloskey E., Mellstrom D., Melton L. J., Pols H., Reeve J., Sanders K., Schott A-M., Silman A., Torgerson D., van Staa T., Watts N. B., Yoshimura N., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women, 10.1007/s00198-007-0343-y
  12. Kanis J. A., Johnell O., Oden A., Johansson H., McCloskey E., FRAX™ and the assessment of fracture probability in men and women from the UK, 10.1007/s00198-007-0543-5
  13. Kanis John A., Johnell Olof, De Laet Chris, Jonsson Bengt, Oden Anders, Ogelsby Alan K., International Variations in Hip Fracture Probabilities: Implications for Risk Assessment, 10.1359/jbmr.2002.17.7.1237
  14. Dawson-Hughes B., Tosteson A. N. A., Melton L. J., Baim S., Favus M. J., Khosla S., Lindsay R. L., Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA, 10.1007/s00198-008-0559-5
  15. Fujiwara S., Nakamura T., Orimo H., Hosoi T., Gorai I., Oden A., Johansson H., Kanis J. A., Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™), 10.1007/s00198-007-0544-4
  16. Lippuner K, Johansson H, Rizzoli R, Kanis JA (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporosis Int 20:1131–1140
  17. Hiligsmann Mickaël, Bruyère Olivier, Ethgen Olivier, Gathon Henry-Jean, Reginster Jean-Yves, Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women, 10.1016/j.bone.2008.08.119
  18. United Nations population division (2003). World population prospects: the 2002 revision and world urban prospects. Population Division of the Dept Economic and Social Affairs of the UN Secretariat.
  19. Kanis J. A., Oden A., Johnell O., Jonsson B., de Laet C., Dawson A., The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds, 10.1007/s001980170112
  20. Boonen S., , Kaufman J.-M., Reginster J.-Y., Devogelaer J.-P., Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium, 10.1007/s00198-002-1321-z
  21. Goemaere Stefan, Vanderschueren Dirk, Kaufman Jean-Marc, Reginster Jean-Yves, Boutsen Yves, Poriau Stefaan, Callens Joris, Raeman Frank, Depresseux Genevieve, Borghs Herman, Devogelaer Jean-Pierre, Boonen Steven, Dual Energy X-Ray Absorptiometry-Based Assessment of Male Patients Using Standardized Bone Density Values and a National Reference Database, 10.1016/j.jocd.2006.10.002
  22. De Laet C., Kanis J. A., Odén A., Johanson H., Johnell O., Delmas P., Eisman J. A., Kroger H., Fujiwara S., Garnero P., McCloskey E. V., Mellstrom D., Melton L. J., Meunier P. J., Pols H. A. P., Reeve J., Silman A., Tenenhouse A., Body mass index as a predictor of fracture risk: A meta-analysis, 10.1007/s00198-005-1863-y
  23. Kanis John A., Oden Anders, Johansson Helena, Borgström Fredrik, Ström Oskar, McCloskey Eugene, FRAX® and its applications to clinical practice, 10.1016/j.bone.2009.01.373
  24. Johansson H., Kanis J. A., Oden A., Johnell O., McCloskey E., BMD, clinical risk factors and their combination for hip fracture prevention, 10.1007/s00198-009-0845-x
  25. Black D. M., Steinbuch M., Palermo L., Dargent-Molina P., Lindsay R., Hoseyni M. S., Johnell O., An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women, 10.1007/s001980170072
  26. Burger H, de Laet C.E.D.H, Weel A.E.A.M, Hofman A, Pols H.A.P, Added value of bone mineral density in hip fracture risk scores, 10.1016/s8756-3282(99)00173-8
  27. Albrand G, Munoz F, Sornay-Rendu E, DuBoeuf F, Delmas P.D, Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study, 10.1016/s8756-3282(02)00919-5
  28. Carroll J, Testa MA, Erat K, LeBoff MS, El-Hajj Fuleihan G (1997) Modelling fracture risk using bone density, age, and years since menopause. Amer J Prevent Med 13:447–452
  29. Dargent-Molina P., Douchin M. N., Cormier C., Meunier P. J., Bréart for the EPIDOS study group* G., Use of Clinical Risk Factors in Elderly Women with Low Bone Mineral Density to Identify Women at Higher Risk of Hip Fracture: The EPIDOS Prospective Study, 10.1007/s001980200078
  30. Girman Cynthia J., Chandler Julie M., Zimmerman Sheryl I., Martin Allison R., Hawkes William, Hebel J. Richard, Sloane Philip D., Magaziner Jay, Prediction of Fracture in Nursing Home Residents, 10.1046/j.1532-5415.2002.50354.x
  31. Honkanen R. J., Honkanen K., Kröger H., Alhava E., Tuppurainen M., Saarikoski S., Risk Factors for Perimenopausal Distal Forearm Fracture, 10.1007/s001980050291
  32. Leslie William D., Metge Colleen, Salamon Elizabeth A., Yuen C. Kin, Bone Mineral Density Testing in Healthy Postmenopausal Women, 10.1385/jcd:5:2:117
  33. Miller Paul D., Barlas Suna, Brenneman Susan K., Abbott Thomas A., Chen Ya-Ting, Barrett-Connor Elizabeth, Siris Ethel S., An Approach to Identifying Osteopenic Women at Increased Short-term Risk of Fracture, 10.1001/archinte.164.10.1113
  34. Westfall G, Methodology for identifying patients at high risk for osteoporotic fracture, 10.1016/s0149-2918(01)80129-6
  35. Colón-Emeric C. S., Colón-Emeric C. S., Pieper C. F., Pieper C. F., Pieper C. F., Artz M. B., Can Historical and Functional Risk Factors be Used to Predict Fractures in Community-Dwelling Older Adults? Development and Validation of a Clinical Tool, 10.1007/s001980200133
  36. van Staa T.P, Leufkens H.G.M, Cooper C, Utility of medical and drug history in fracture risk prediction among men and women, 10.1016/s8756-3282(02)00848-7
  37. van Staa T.-P., Geusens P., Pols H.A.P., de Laet C., Leufkens H.G.M., Cooper C., A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids, 10.1093/qjmed/hci029
  38. McGrother C. W., Donaldson M. M. K., Clayton D., Abrams K. R., Clarke M., Evaluation of a Hip Fracture Risk Score for Assessing Elderly Women: The Melton Osteoporotic Fracture (MOF) Study, 10.1007/s198-002-8343-6
  39. Walter Louise C., Lui Li-Yung, Eng Catherine, Covinsky Kenneth E., Risk of Hip Fracture in Disabled Community-Living Older Adults, 10.1034/j.1601-5215.2002.51009.x
  40. Nguyen N. D., Frost S. A., Center J. R., Eisman J. A., Nguyen T. V., Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks, 10.1007/s00198-008-0588-0
  41. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV (2008) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397
  42. Kanis JA, Oden A, Johansson H, Borgström F, Ström O (2009) McCloskey E (2009)FRAX® and its applications to clinical practice. Bone 44:734–743
  43. Committee for Medicinal Products for Human Use (CHMP) (2006) Guideline on the evaluation of Medicinal products in the treatment of primary osteoporosis. Ref CPMP/EWP/552/95Rev.2. London, CHMP. Nov 2006.
  44. Saag Kenneth G., Emkey Ronald, Schnitzer Thomas J., Brown Jacques P., Hawkins Federico, Goemaere Stefan, Thamsborg Gorm, Liberman Uri A., Delmas Pierre D., Malice Marie-Pierre, Czachur Michelle, Daifotis Anastasia G., Lane Nancy, Correa-Rotter Ricardo, Yanover Melissa, Westhovens Rene, Epstein Sol, Adachi Jonathan D., Poubelle Patrice, Melo-Gomes Jose, Rodriguez-Portales Jose A., Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis, 10.1056/nejm199807303390502
  45. Adachi Jonathan D., Saag Kenneth G., Delmas Pierre D., Liberman Uri A., Emkey Ronald D., Seeman Ego, Lane Nancy E., Kaufman Jean-Marc, Poubelle Patrice E. E., Hawkins Federico, Correa-Rotter Ricardo, Menkes Charles-Joel, Rodriguez-Portales Jose A., Schnitzer Thomas J., Block Joel A., Wing Jeffrey, McIlwain Harris H., Westhovens Rene, Brown Jacques, Melo-Gomes Jose A., Gruber Barry L., Yanover Melissa J., Leite Maria Odette R., Siminoski Kerry G., Nevitt Michael C., Sharp John T., Malice Marie-Pierre, Dumortier Thomas, Czachur Michelle, Carofano Wendy, Daifotis Anastasia, Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial, 10.1002/1529-0131(200101)44:1<202::aid-anr27>;2-w
  46. Reginster J.-Y., Minne H. W., Sorensen O. H., Hooper M., Roux C., Brandi M. L., Lund B., Ethgen D., Pack S., Roumagnac I., Eastell R., Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis, 10.1007/s001980050010
  47. Writing Group for the Women's Health Initiative Investigators, Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial, 10.1001/jama.288.3.321
  48. McCloskey Eugene V, Beneton Monique, Charlesworth Diane, Kayan Karthik, de Takats Dominic, Dey Abhijit, Orgee Jane, Ashford Robert, Forster Martin, Cliffe Jennifer, Kersh Linda, Brazier John, Nichol Jon, Aropuu Sakari, Jalava Tarja, Kanis John A, Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized Study, 10.1359/jbmr.061008
  49. Chapuy M C, Arlot M E, Delmans P D, Meunier P J, Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women, 10.1136/bmj.308.6936.1081
  50. Kanis J. A., Barton I. P., Johnell O., Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture, 10.1007/s00198-004-1698-y
  51. McCloskey Eugene, Selby Peter, Davies Mike, Robinson John, Francis Roger M, Adams Judith, Kayan Karthik, Beneton Monique, Jalava Tarja, Pylkkänen Liisa, Kenraali Juha, Aropuu Sakari, Kanis John A, Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double-Blind, Placebo-Controlled 3-Year Study, 10.1359/jbmr.040116
  52. Roux Christian, Reginster Jean-Yves, Fechtenbaum Jacques, Kolta Sami, Sawicki Andrzej, Tulassay Zsolt, Luisetto Giovanni, Padrino José-Maria, Doyle David, Prince Richard, Fardellone Patrice, Sorensen Ole Helmer, Meunier Pierre Jean, Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors, 10.1359/jbmr.060101
  53. Marcus Robert, Wang Ouhong, Satterwhite Julie, Mitlak Bruce, The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis, 10.1359/jbmr.2003.18.1.18
  54. Johnell Olof, Kanis John A, Black Dennis M, Balogh Adam, Poor Gyula, Sarkar Somnath, Zhou Chunmei, Pavo Imre, Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study, 10.1359/jbmr.040211
  55. Johansson Helena, Oden Anders, Johnell Olof, Jonsson Bengt, de Laet Chris, Oglesby Alan, McCloskey Eugene V, Kayan Karthik, Jalava Tarja, Kanis John A, Optimization of BMD Measurements to Identify High Risk Groups for Treatment-A Test Analysis, 10.1359/jbmr.2004.19.6.906
  56. McCloskey E. V., Johansson H., Oden A., Vasireddy S., Kayan K., Pande K., Jalava T., Kanis J. A., Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study, 10.1007/s00198-008-0786-9
  57. Kanis JA, Johansson H, Oden A, McCloskey EV (2009) Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®. Bone 44:49–54
  58. Johansson H, Kanis JA, Borgström F, Ström O, Svensson O, Mellström D (2009) FRAX® ett stöd för frakturprevention. Lakar Tidningen
  59. Kanis J. A., McCloskey E. V., Johansson H., Strom O., Borgstrom F., Oden A., , Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK, 10.1007/s00198-008-0712-1